These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

92 related articles for article (PubMed ID: 12400405)

  • 21. Variant Creutzfeldt-Jakob disease and prions in the blood supply.
    Rohwer RG; Drohan W
    Clin Adv Hematol Oncol; 2004 Feb; 2(2):84, 87, 131. PubMed ID: 16163166
    [No Abstract]   [Full Text] [Related]  

  • 22. An update on the assessment and management of the risk of transmission of variant Creutzfeldt-Jakob disease by blood and plasma products.
    Turner ML; Ludlam CA
    Br J Haematol; 2009 Jan; 144(1):14-23. PubMed ID: 18950452
    [TBL] [Abstract][Full Text] [Related]  

  • 23. An overview of prion biology and the role of blood filtration in reducing the risk of transfusion-transmitted variant Creutzfeldt-Jakob disease.
    Cervia JS; Sowemimo-Coker SO; Ortolano GA; Wilkins K; Schaffer J; Wortham ST
    Transfus Med Rev; 2006 Jul; 20(3):190-206. PubMed ID: 16787827
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Universal leucodepletion to reduce the risk of transmission of new-variant Creutzfeldt-Jakob disease.
    Sivakumaran M
    Br J Haematol; 2000 Jul; 110(1):234. PubMed ID: 10991551
    [No Abstract]   [Full Text] [Related]  

  • 25. Prion safety of transfusion plasma and plasma-derivatives typically used for prophylactic treatment.
    Svae TE; Neisser-Svae A; Bailey A; Reichl H; Biesert L; Schmidt T; Heger A; Römisch J
    Transfus Apher Sci; 2008 Aug; 39(1):59-67. PubMed ID: 18619902
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Creutzfeldt-Jakob disease and transfusion safety: tilting at icebergs?
    Dodd RY; Sullivan MT
    Transfusion; 1998 Mar; 38(3):221-3. PubMed ID: 9563399
    [No Abstract]   [Full Text] [Related]  

  • 27. Removal of TSE agents from blood products.
    Foster PR
    Vox Sang; 2004 Jul; 87 Suppl 2():7-10. PubMed ID: 15209867
    [No Abstract]   [Full Text] [Related]  

  • 28. American fresh frozen plasma for neonates and children.
    Norfolk DR; Glaser A; Kinsey S
    Arch Dis Child; 2005 Jan; 90(1):89-91. PubMed ID: 15613525
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Managing the risk of transmission of variant Creutzfeldt Jakob disease by blood products.
    Ludlam CA; Turner ML
    Br J Haematol; 2006 Jan; 132(1):13-24. PubMed ID: 16371015
    [TBL] [Abstract][Full Text] [Related]  

  • 30. US blood ban underlines CJD fears.
    Wadman M
    Nature; 2001 Jul; 412(6842):7. PubMed ID: 11452271
    [No Abstract]   [Full Text] [Related]  

  • 31. Creutzfeldt-Jakob disease: reflections on the risk from blood product therapy.
    Brown P
    Haemophilia; 2007 Dec; 13 Suppl 5():33-40. PubMed ID: 18078395
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Of mad cows and bolted horses: the economics of blood safety.
    Murphy WG
    Transfusion; 2012 Nov; 52(11):2278-81. PubMed ID: 23140426
    [No Abstract]   [Full Text] [Related]  

  • 33. [The impact of the implementation of staying in the United Kingdom for six months or more as donor exclusion criteria on the donor base of the Basque Country].
    Pérez Vaquero MA; Basaldua MA; Ibarra A; Renovales A; Larrea A; Vesga MA
    Med Clin (Barc); 2001 Mar; 116(11):413-5. PubMed ID: 11333688
    [TBL] [Abstract][Full Text] [Related]  

  • 34. New variant Creutzfeldt-Jakob disease: a controversial but potential blood transfusion risk.
    Basu A
    Nepal Med Coll J; 2003 Jun; 5(1):51-2. PubMed ID: 16583978
    [No Abstract]   [Full Text] [Related]  

  • 35. Leucocyte depletion of the blood supply - how will patients benefit?
    Williamson LM
    Br J Haematol; 2000 Aug; 110(2):256-72. PubMed ID: 10971381
    [No Abstract]   [Full Text] [Related]  

  • 36. Lack of evidence of transfusion transmission of Creutzfeldt-Jakob disease in a US surveillance study.
    Dorsey K; Zou S; Schonberger LB; Sullivan M; Kessler D; Notari E; Fang CT; Dodd RY
    Transfusion; 2009 May; 49(5):977-84. PubMed ID: 19170987
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Mad cow mania.
    Ortolon K
    Tex Med; 2004 Mar; 100(3):41-4. PubMed ID: 15146763
    [No Abstract]   [Full Text] [Related]  

  • 38. Blood supplies to be treated to reduce CJD risk.
    Warden J
    BMJ; 1998 Jul; 317(7153):232. PubMed ID: 9729069
    [No Abstract]   [Full Text] [Related]  

  • 39. Blood supplies hit by vCJD fear.
    Strachan-Bennett S
    Nurs Times; 2004 Jan 6-12; 100(1):6. PubMed ID: 14735624
    [No Abstract]   [Full Text] [Related]  

  • 40. Blood-transmitted prions and variant Creutzfeldt-Jakob disease.
    Grady GF; Vyas GN
    Biologicals; 2007 Apr; 35(2):75-7. PubMed ID: 17317213
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.